Vitrolife AB

VITR

Company Profile

  • Business description

    Vitrolife AB provides medical devices and genetic testing services intended for the reproductive-health market in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics (in vitro fertilization) in enhancing their practice as well as the outcome of a patient's fertility treatment, thereby enabling patients to receive support to navigate the complexities of reproductive health through successful outcomes and patient satisfaction. The company has three geographical segments EMEA, Americas and APAC, out of which it derives maximum revenue from EMEA.

  • Contact

    Box 9080
    Gothenburg400 92
    SWE

    T: +46 317218000

    https://www.vitrolife.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2026

    Employees

    1,116

Stocks News & Analysis

stocks

This ASX miner is the cheapest in our iron ore coverage

High debt levels and low commodity prices were a concern, but agreed sell-downs and a ramp-up of key operations should help.
stocks

Apple names new CEO as Tim Cook steps aside after 15 years

John Ternus, Apple’s hardware chief, will take up the role in September.
stocks

Updating our commodity price assumptions

Our view as China’s steel production drops.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,074.4050.80-0.56%
CAC 408,210.7624.95-0.30%
DAX 4024,247.0723.80-0.10%
Dow JONES (US)49,149.38293.18-0.59%
FTSE 10010,491.057.04-0.07%
HKSE26,163.24324.24-1.22%
NASDAQ24,259.96144.43-0.59%
Nikkei 22559,585.86236.690.40%
NZX 50 Index12,945.6013.270.10%
S&P 5007,064.010.000.00%
S&P/ASX 2008,843.6053.20-0.60%
SSE Composite Index4,106.2621.180.52%

Market Movers